Charter Oak Equity
3
13M
3
0.19
1
- Areas of investment
Summary
Charter Oak Equity appeared to be the Corporate Investor, which was created in 2006. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Westport.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Charter Oak Equity, startups are often financed by Lurie Investment Fund, Apjohn ventures, North Coast Technology Investors. The meaningful sponsors for the fund in investment in the same round are ONSET Ventures, North Coast Technology Investors, Lyrical Partners.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2012. Deals in the range of 10 - 50 millions dollars are the general things for fund.
We can highlight the next thriving fund investment areas, such as Software, Child Care. Among the most popular portfolio startups of the fund, we may highlight CytoPherx, SmartCare. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.19
- Investments by industry
- Health Care (2)
- Life Science (1)
- Medical Device (1)
- Real Time (1)
- Software (1) Show 6 more
- Investments by region
-
- United States (2)
- Canada (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CytoPherx | 04 Jan 2012 | Health Care, Medical Device, Life Science | Late Stage Venture | 34M | United States, Ann Arbor, Michigan |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.